Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Amesika N. Nyaku"'
Autor:
Amesika N. Nyaku, Erin A. Zerbo, Clement Chen, Nicole Milano, Barbara Johnston, Randall Chadwick, Stephanie Marcello, Kaitlan Baston, Rachel Haroz, Stephen Crystal
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Opioid-involved overdose deaths continue to rise in the US, despite availability of highly effective treatments for opioid use disorder (OUD), in part due to the insufficient number of treatment providers. Barriers include the nee
Externí odkaz:
https://doaj.org/article/2fde87c88ff94638a49930780b64f845
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
Background Racial and ethnic disparities are evident in the accessibility of treatment for opioid use disorder (OUD). Even when medications for OUD (MOUD) are accessible, racially and ethnically minoritized groups have higher attrition rates from tre
Externí odkaz:
https://doaj.org/article/b94c1d454fbe4a018c2174ff40f1a2af
Autor:
Michael Enich, Rachel Flumo, Stephanie Campos, Netanya Flores, Nora Sullivan, Jenna Mellor, Caitlin O'Neill, Amesika N. Nyaku
Publikováno v:
Preventive Medicine Reports, Vol 35, Iss , Pp 102374- (2023)
People who use drugs (PWUD) are the most directly affected by the overdose epidemic. However, they are not often targets of overdose education and naloxone distribution (OEND) programs. Instead, these programs target friends or family members of peop
Externí odkaz:
https://doaj.org/article/dd0994ee7b6e49eab2d36b415ddadd68
Publikováno v:
IDCases, Vol 27, Iss , Pp e01378- (2022)
We describe an atypical presentation of malaria in a 19-year-old female who emigrated from Nigeria to the United States one year prior to presentation. Her primary complaint was fever and occipital headache radiating down to the neck. Rapid antigen t
Externí odkaz:
https://doaj.org/article/d5d959a89e054458b0849828f4b3403d
Autor:
Samuel D. Maldonado, Amesika N. Nyaku, Swetha Kodali, Jeffrey M. Paer, Alexander W. Sudyn, Garry Closeil, Gregory Sugalski, Anthony Grygotis, Shobha Swaminathan
Publikováno v:
AIDS Patient Care and STDs. 36:51-54
HIV Prevention Research Experiences Among Men Who Have Sex With Men and Transgender Persons of Color
Autor:
Aparna Alankar, Jamir Tuten, Travis Love, Jennifer Punsal, Shobha Swaminathan, Amesika N. Nyaku
Publikováno v:
Journal of racial and ethnic health disparities.
Purpose Black and Latinx MSM and transgender POC disproportionately experience new HIV diagnoses. Determining effective HIV prevention methods requires the inclusion of these communities in research and thorough post-trial experience evaluations. Thi
Publikováno v:
Addictive Behaviors. 126:107182
Rates of injection drug use (IDU) of opioids have been consistently lower among Black people relative to Non-Hispanic White people despite rising IDU estimates. While explanations have been proposed, no study has explored differences within a clinica
Autor:
Carl J. Fichtenbaum, Jonathan Z. Li, Susan L. Koletar, Amesika N. Nyaku, Jonathan Colasanti, Baiba Berzins, Carlee Moser, Constance A. Benson, Vincent C. Marconi, Babafemi Taiwo, Timothy J. Wilkin, Paul E. Sax, Edward P. Acosta
Publikováno v:
Clinical Infectious Diseases. 66:1794-1797
In this randomized pilot clinical trial, dolutegravir plus lamivudine was noninferior to continuation of standard 3-drug maintenance antiretroviral therapy. There was no emergence of drug resistance in the participant who experienced virologic failur
Autor:
Amesika N. Nyaku, Edward P. Acosta, Andrei Stefanescu, David W. Haas, Roy M. Gulick, Catherine Godfrey, Paul E. Sax, Carole L. Wallis, Kimberly Y. Smith, Beverly Sha, Lu Zheng, Baiba Bezins, Babafemi Taiwo, Cornelius N Van Dam
Publikováno v:
Clinical Infectious Diseases. 66:1689-1697
BACKGROUND: Limited data exist on initial human immunodeficiency virus type 1 (HIV-1) treatment with dolutegravir plus lamivudine. METHODS: A5353 is a phase 2, single-arm, pilot study of once-daily dolutegravir (50 mg) plus lamivudine (300 mg) in tre
Autor:
Jan Gryczynski, Lisa A. Marsch, Keith Goldfeld, Mia Malone, Robert P. Schwartz, Wendy Martin, Laura B. Monico, Kathleen Bell, Rusty Reeves, Kasey Talon, Anna Cheng, Joshua D. Lee, Amesika N. Nyaku, Sandra Violette, David Farabee, Randy Torralva, Nicole Beckwith, Sandra A. Springer, Jennifer P. Wisdom, Elizabeth Needham Waddell, Kasey Harding, Ryan McDonald, Elizabeth C. Saunders, Andrew Suchocki, Thomas Groblewski
Publikováno v:
J Subst Abuse Treat
The EXIT-CJS (N = 1005) multisite open-label randomized controlled trial will compare retention and effectiveness of extended-release buprenorphine (XR-B) vs. extended-release naltrexone (XR-NTX) to treat opioid use disorder (OUD) among criminal just